LaurenRWeintraubMD

Pediatric Hematology & Oncology • Albany, NY

Physician

Join to view full profile

Dr. Weintraub is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weintraub's full profile

Already have an account?

Office
47 New Scotland Ave
Albany, NY 12208
Phone+1 518-262-5513

Fax+1 518-262-5889

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 2008 - 2011
Tufts University School of MedicineClass of 2008

Certifications & Licensure

NY State Medical License 2010 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer Start of enrollment: 2017 Nov 29
Active, not recruiting
Phase 3
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 2
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
Recruiting
Phase 3
MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
Active, not recruiting
Phase 2
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Available
Roles: Contact
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Start of enrollment: 2023 Jan 23
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.
Rose Parisi, Roshal R Patel, Gavrielle Rood, Acacia Bowden, George Turco
Pediatric Blood & Cancer. 2023-03-01
2 citations
Posterior reversible encephalopathy syndrome and necrotizing enterocolitis in a pediatric patient with medulloblastoma and COVID-19 infection.
Jacob Naman, Nicole Saglamer, Torun Yock, John Pugh, Gaetano Pastena
Pediatric Blood & Cancer. 2023-01-01
Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.
Carol Fries, Angela R Girvin, David N. Korones, Lauren Weintraub, Lorna K. Fitzpatrick
Journal of Pediatric Hematology/oncology. 2021-05-18